Načítá se...
Erythropoietin Supports the Survival of Prostate Cancer, But Not Growth and Bone Metastasis
Erythropoietin (Epo) is used in clinical settings to enhance hematopoietic function and to improve the quality of life for patients undergoing chemotherapy by reducing fatigue and the need for transfusions. However, several meta-analyses have revealed that Epo treatments are associated with an incre...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3978144/ https://ncbi.nlm.nih.gov/pubmed/23696192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.24592 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|